Advertisement
Screener

CRYOPORT, INC. (CYRX) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

CRYOPORT, INC. Increase (Decrease) in Accounts Receivable

CRYOPORT, INC. (CYRX) reported Increase (Decrease) in Accounts Receivable of $147.25 thousand for the 6-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2015-11-16

  • CRYOPORT, INC. increase (decrease) in accounts receivable for the quarter ending 2015-09-30 was -$23.82K.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for the quarter ending 2015-06-30 was $171.08K.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for the quarter ending 2015-03-31 was $184.49K.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for the quarter ending 2014-12-31 was -$621.00, a 100.25% decline year-over-year.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for fiscal 2015 was $76.59K, a 76.33% decline from fiscal 2014.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for fiscal 2014 was $323.60K, a 355.95% increase from fiscal 2013.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for fiscal 2013 was $70.97K, a 21.43% decline from fiscal 2012.
  • CRYOPORT, INC. increase (decrease) in accounts receivable for fiscal 2012 was $90.33K.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2015-09-30-$23.82K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16
$147.25K
10-Q · filed 2015-11-16
$331.74K
derived: sum of 3 quarters · filed 2015-11-16
$331.12K
derived: sum of 4 quarters · filed 2015-11-16
2015-06-30$171.08K
10-Q · filed 2015-08-06
$355.56K
derived: sum of 2 quarters · filed 2015-08-06
$354.94K
derived: sum of 3 quarters · filed 2015-08-06
$275.97K
derived: sum of 4 quarters · filed 2015-11-16
2015-03-31$184.49K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19
$183.87K
derived: sum of 2 quarters · filed 2015-05-19
$104.90K
derived: sum of 3 quarters · filed 2015-11-16
$76.59K
10-K · filed 2015-05-19
2014-12-31-$621.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05
-$79.59K
derived: sum of 2 quarters · filed 2015-11-16
-$107.90K
10-Q · filed 2015-02-05
-$202.89K
derived: sum of 4 quarters · filed 2015-11-16
2014-09-30-$78.97K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16
-$107.28K
10-Q · filed 2015-11-16
-$202.27K
derived: sum of 3 quarters · filed 2015-11-16
$45.75K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30-$28.31K
10-Q · filed 2015-08-06
-$123.30K
derived: sum of 2 quarters · filed 2015-08-06
$124.72K
derived: sum of 3 quarters · filed 2015-08-06
$154.69K
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31-$94.99K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19
$153.03K
derived: sum of 2 quarters · filed 2015-05-19
$183.00K
derived: sum of 3 quarters · filed 2015-05-19
$323.60K
10-K · filed 2015-05-19
2013-12-31$248.02K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05
$277.99K
derived: sum of 2 quarters · filed 2015-02-05
$418.59K
10-Q · filed 2015-02-05
$434.55K
derived: sum of 4 quarters · filed 2015-02-05
2013-09-30$29.97K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12
$170.57K
10-Q · filed 2014-11-12
$186.53K
derived: sum of 3 quarters · filed 2014-11-12
$217.30K
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$140.60K
10-Q · filed 2014-07-31
$156.56K
derived: sum of 2 quarters · filed 2014-07-31
$187.33K
derived: sum of 3 quarters · filed 2014-07-31
$212.94K
derived: sum of 4 quarters · filed 2014-07-31
2013-03-31$15.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25
$46.73K
derived: sum of 2 quarters · filed 2014-06-25
$72.33K
derived: sum of 3 quarters · filed 2014-06-25
$70.97K
10-K · filed 2014-06-25
2012-12-31$30.77K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13
$56.37K
derived: sum of 2 quarters · filed 2014-02-13
$55.01K
10-Q · filed 2014-02-13
$117.43K
derived: sum of 4 quarters · filed 2014-02-13
2012-09-30$25.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18
$24.24K
10-Q · filed 2013-11-18
$86.66K
derived: sum of 3 quarters · filed 2013-11-18
$58.98K
derived: sum of 4 quarters · filed 2013-11-18
2012-06-30-$1.36K
10-Q · filed 2013-08-14
$61.06K
derived: sum of 2 quarters · filed 2013-08-14
$33.38K
derived: sum of 3 quarters · filed 2013-08-14
$68.82K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$62.42K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25
$34.74K
derived: sum of 2 quarters · filed 2013-06-25
$70.18K
derived: sum of 3 quarters · filed 2013-06-25
$90.33K
10-K · filed 2013-06-25
2011-12-31-$27.68K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14
$7.76K
derived: sum of 2 quarters · filed 2013-02-14
$27.91K
10-Q · filed 2013-02-14
$47.78K
derived: sum of 4 quarters · filed 2013-02-14
2011-09-30$35.44K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09
$55.59K
10-Q · filed 2012-11-09
$75.46K
derived: sum of 3 quarters · filed 2012-11-09
$52.45K
derived: sum of 4 quarters · filed 2012-11-09
2011-06-30$20.15K
10-Q · filed 2012-08-14
$40.02K
derived: sum of 2 quarters · filed 2012-08-14
$17.00K
derived: sum of 3 quarters · filed 2012-08-14
$43.13K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$19.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27
-$3.15K
derived: sum of 2 quarters · filed 2012-06-27
$22.98K
derived: sum of 3 quarters · filed 2012-06-27
-$25.24K
10-K · filed 2012-06-27
2010-12-31-$23.02K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-21
$3.11K
derived: sum of 2 quarters · filed 2012-02-21
-$45.11K
10-Q · filed 2012-02-21
2010-09-30$26.12K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14
-$22.10K
10-Q · filed 2011-11-14
2010-06-30-$48.22K
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71